Icon - Our staff

Our staff

Interim Chief Executive Officer
Dr Lisa Murphy

Lisa Murphy has been with Kidney Health Australia since 2016, initially as the National Kidney Cancer Program General Manager, moving into a Medical Advisor role and then into her current usual role as General Manager for KHA Research.  Lisa is keen to maintain the momentum at Kidney Health Australia in supporting Australians affected by kidney disease through our focus on Community, Advocacy and Research.

Lisa qualified as a medical doctor in the UK with a board scientific and medical training including; a 1st class honours degree in psychology and physiology, a degree in Medicine from Imperial College London, post graduate certification in medicine (MRCP) and specialist training in anaesthetics and intensive care.

Lisa moved to Melbourne with her family in 2010. In looking after her 2 sons who have type 1 diabetes, Lisa embarked on a career change, initially in medical writing and education and then into the For Purpose sector. When not at work Lisa loves spending time with her boys and cycling. 

Clinical Director
Dr Shilpa Jesudason 

Dr Jesudason was appointed as Clinical Director at KHA in 2017.

Shilpa is a Staff Specialist Nephrologist and consults in Obstetric Nephrology, General Nephrology and Transplantation at the Central and Northern Adelaide Renal and Transplantation Service (CNARTS) Royal Adelaide Hospital, and the Women's and Children's Hospital, Adelaide.

She trained at the Royal Adelaide Hospital, Flinders Medical Centre and St Mary's Hospital Transplant Unit in London before returning in 2004 to undertake PhD studies in transplantation immunology at the Basil Hetzel Institute, Queen Elizabeth Hospital.

Her current clinical interests include the management of pregnancy-related issues in women with renal disease, including all stages of CKD, dialysis and transplant patients, living kidney donors and women with hypertension. She is also interested in the immunological pathogenesis of pre-eclampsia and pregnancy as a model for immune tolerance relevant to transplantation, as well as the long-term sequelae of pre-eclampsia. Her current research projects involve defining the peripheral blood immune phenotype in normal pregnancy and pre-eclampsia, using population health datasets to address maternal and foetal outcomes in pregnancies from women with renal disease, and defining patient and clinician perspectives through qualitative research methods.

Chief Financial Officer
Matthew Hubbard

General Manager Clinical Directorate
Dr Marie Ludlow BA (Hons) PhD

General Manager Priscilla Kincaid-Smith Kidney Research Foundation
Dr Lisa Murphy

Fundraising, Marketing and Communications General Manager
Marcia Christmas

 

About usOur partners
Join our community to download